Skip to main content
OTCMKTS:AHACU

Alpha Healthcare Acquisition News Headlines

$10.93
-0.26 (-2.32 %)
(As of 05/14/2021 04:00 PM ET)
Add
Compare
Today's Range
$10.93
$11.21
50-Day Range
$10.81
$13.01
52-Week Range
$9.83
$20.23
Volume1,703 shs
Average Volume34,902 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Alpha Healthcare Acquisition (OTCMKTS AHACU) News Headlines Today

SourceHeadline
Soliton: A Smart Acquisition, Even As It Spoils Price Action PotentialSoliton: A Smart Acquisition, Even As It Spoils Price Action Potential
seekingalpha.com - May 12 at 3:08 PM
ATP Assays Market Worth $315 Million By 2024ATP Assays Market Worth $315 Million By 2024
seekingalpha.com - May 5 at 9:24 AM
Interactive Patient Engagement Solutions Market To Reach USD 291 Million By 2026Interactive Patient Engagement Solutions Market To Reach USD 291 Million By 2026
seekingalpha.com - May 5 at 9:24 AM
Whats Next for SPACsWhat's Next for SPACs
thestreet.com - May 5 at 9:24 AM
SPAC Ideas for TuesdaySPAC Ideas for Tuesday
thestreet.com - May 4 at 7:59 AM
Global Thalassemia Treatment Market is estimated to be US$ 14.7 billion by 2030 with a CAGR of 10.40% during the forecast period - By PMIGlobal Thalassemia Treatment Market is estimated to be US$ 14.7 billion by 2030 with a CAGR of 10.40% during the forecast period - By PMI
ca.finance.yahoo.com - April 30 at 6:26 PM
Physiotherapy Equipment Market - Increasing Use Of New Technologically Advanced ProductsPhysiotherapy Equipment Market - Increasing Use Of New Technologically Advanced Products
seekingalpha.com - April 30 at 8:25 AM
Consulting Services Market - Growing Demand For Digital Consultancy In Healthcare IndustryConsulting Services Market - Growing Demand For Digital Consultancy In Healthcare Industry
seekingalpha.com - April 29 at 5:24 PM
Alpha Healthcare Acquisition M&A Partner Humacyte Announces Long-Term Follow-Up Data From Phase 2 Vascular Access TrialAlpha Healthcare Acquisition M&A Partner Humacyte Announces Long-Term Follow-Up Data From Phase 2 Vascular Access Trial
benzinga.com - April 21 at 6:36 PM
The Power of the Platform in Psychedelic MedicineThe Power of the Platform in Psychedelic Medicine
marketwatch.com - April 20 at 9:29 AM
Humacyte Secures $50 Million Debt Facility with Silicon Valley BankHumacyte Secures $50 Million Debt Facility with Silicon Valley Bank
finance.yahoo.com - April 14 at 8:27 AM
Accelalpha Acquires Key Performance IdeasAccelalpha Acquires Key Performance Ideas
finance.yahoo.com - April 13 at 12:22 PM
Abu Dhabi’s IHC Adds Stake in Top UAE Builder With New DealAbu Dhabi’s IHC Adds Stake in Top UAE Builder With New Deal
finance.yahoo.com - April 13 at 7:21 AM
3 Pre-Deal SPACs to Consider: TBCP, DFPH, FCAX3 Pre-Deal SPACs to Consider: TBCP, DFPH, FCAX
thestreet.com - April 8 at 1:23 PM
Global Healthcare PPE Demand Market 2020-2025: Size, Share, Industry Price, Report and ForecastGlobal Healthcare PPE Demand Market 2020-2025: Size, Share, Industry Price, Report and Forecast
marketwatch.com - April 6 at 6:38 PM
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Alpha Healthcare Acquisition Corp. - AHACSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Alpha Healthcare Acquisition Corp. - AHAC
finance.yahoo.com - March 27 at 2:49 AM
Humacyte CEO Dr. Laura Niklason and Alpha Healthcare CEO Rajiv Shukla to Present at CED Venture Connect 2021 Online SummitHumacyte CEO Dr. Laura Niklason and Alpha Healthcare CEO Rajiv Shukla to Present at CED Venture Connect 2021 Online Summit
finance.yahoo.com - March 23 at 12:19 PM
3 Stocks Cathie Wood Likes That Should Make You Rich3 Stocks Cathie Wood Likes That Should Make You Rich
fool.com - March 22 at 6:12 AM
SPAC, Accelerate Acquisition prices $400M IPOSPAC, Accelerate Acquisition prices $400M IPO
seekingalpha.com - March 19 at 6:10 PM
Global Lewy Body Dementia Treatment Market (2020 to 2027) - Share, Size, Trends, Industry Analysis ReportGlobal Lewy Body Dementia Treatment Market (2020 to 2027) - Share, Size, Trends, Industry Analysis Report
marketwatch.com - March 19 at 1:09 PM
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLUE, MPLN and IQDNXThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLUE, MPLN and IQDNX
marketwatch.com - March 17 at 1:23 AM
Acadia Healthcare: A US-Focused Behavioral Health PlayAcadia Healthcare: A US-Focused Behavioral Health Play
seekingalpha.com - March 15 at 6:46 PM
R1 RCM Is Increasingly Entrenched In The U.S. Healthcare Sector, We See Further UpsideR1 RCM Is Increasingly Entrenched In The U.S. Healthcare Sector, We See Further Upside
seekingalpha.com - March 13 at 7:28 AM
DLA Piper advises Piper Sandler & Co. as placement agent in US$175 million PIPE for Alpha Healthcare Acquisition Corp.DLA Piper advises Piper Sandler & Co. as placement agent in US$175 million PIPE for Alpha Healthcare Acquisition Corp.
finance.yahoo.com - March 2 at 6:51 PM
Apollo Healthcare: A Revitalized CPG Company Flying Under The RadarApollo Healthcare: A Revitalized CPG Company Flying Under The Radar
seekingalpha.com - February 24 at 3:44 PM
Looking to ride the SPAC train to go public? Do this first, Raleigh attorneys sayLooking to ride the SPAC train to go public? Do this first, Raleigh attorneys say
bizjournals.com - February 22 at 5:01 PM
Why Humacyte Is Going Public Via SPACWhy Humacyte Is Going Public Via SPAC
msn.com - February 18 at 11:11 PM
Human tissue developer Humacyte agrees to SPAC merger to go publicHuman tissue developer Humacyte agrees to SPAC merger to go public
reuters.com - February 17 at 7:47 PM
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Alpha Healthcare Acquisition Corp. (Nasdaq - AHAC)SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Alpha Healthcare Acquisition Corp. (Nasdaq - AHAC)
finance.yahoo.com - February 17 at 7:47 PM
Human tissue developer Humacyte nears SPAC deal to go public: sourcesHuman tissue developer Humacyte nears SPAC deal to go public: sources
reuters.com - February 17 at 2:46 PM
Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisition Corp.Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisition Corp.
finance.yahoo.com - February 17 at 9:45 AM
Molina Healthcare, Inc. (MOH) CEO Joseph Zubretsky on Q4 2020 Results - Earnings Call TranscriptMolina Healthcare, Inc. (MOH) CEO Joseph Zubretsky on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 12 at 3:48 PM
Hims & Hers: A Digital Front Door To The Healthcare SystemHims & Hers: A Digital Front Door To The Healthcare System
seekingalpha.com - February 2 at 6:39 PM
Surgical Face Shield Industry Research Report 2021 by Type, Applications, Regions, Market Size Estimation and Forecast to 2025Surgical Face Shield Industry Research Report 2021 by Type, Applications, Regions, Market Size Estimation and Forecast to 2025
marketwatch.com - January 27 at 12:44 PM
WeLink Lands $185 Million In Financing For 5G Network RolloutWeLink Lands $185 Million In Financing For 5G Network Rollout
pymnts.com - January 8 at 11:57 PM
UnitedHealth’s Change deal signals plans to expand Optum – CitiUnitedHealth’s Change deal signals plans to expand Optum – Citi
seekingalpha.com - January 8 at 1:55 PM
3 Beaten-Down Growth Stocks That Can Soar in 20213 Beaten-Down Growth Stocks That Can Soar in 2021
fool.com - December 23 at 7:14 AM
5 Unconventional Chinese Tech Stocks To Buy Before 20215 Unconventional Chinese Tech Stocks To Buy Before 2021
seekingalpha.com - December 22 at 6:07 AM
The REIT Millionaire MakerThe REIT Millionaire Maker
seekingalpha.com - December 20 at 9:54 AM
Apollo Healthcare: Undervalued Consumer Products Company With 200%+ Return PotentialApollo Healthcare: Undervalued Consumer Products Company With 200%+ Return Potential
seekingalpha.com - December 14 at 1:31 PM
Alpha Healthcare Acquisition Corp. Announces Pricing of $100,000,000 Initial Public OfferingAlpha Healthcare Acquisition Corp. Announces Pricing of $100,000,000 Initial Public Offering
finance.yahoo.com - December 14 at 8:30 AM
Alpha Healthcare Acquisition Corp. Announces Closing of $100,000,000 Initial Public OfferingAlpha Healthcare Acquisition Corp. Announces Closing of $100,000,000 Initial Public Offering
finance.yahoo.com - December 14 at 8:30 AM
Alpha Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing November 9, 2020Alpha Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing November 9, 2020
finance.yahoo.com - December 14 at 8:30 AM
This page was last updated on 5/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.